Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Luciana J. Jahns"'
Autor:
Filiz Cicek, Sascha Troschke-Meurer, Kiraz Ceylan, Luciana J. Jahns, Maxi Zumpe, Nikolai Siebert, Karoline Ehlert, Holger N. Lode
Publikováno v:
Frontiers in Pediatrics, Vol 8 (2020)
Patients with high-risk neuroblastoma treated with continuous long-term infusion of anti-GD2 antibody dinutuximab beta (DB) in combination with IL-2 show an acceptable safety profile. Here, we compared treatment tolerance with and without IL-2. Ninet
Externí odkaz:
https://doaj.org/article/d64eecd9b1d8462d88e41db19379f01a
Autor:
Sascha Troschke-Meurer, Karoline Ehlert, Maxi Zumpe, Kiraz Ceylan, Filiz Cicek, Luciana J. Jahns, Holger N. Lode, Nikolai Siebert
Publikováno v:
Frontiers in Pediatrics
Frontiers in Pediatrics, Vol 8 (2020)
Frontiers in Pediatrics, Vol 8 (2020)
Patients with high-risk neuroblastoma treated with continuous long-term infusion of anti-GD2 antibody dinutuximab beta (DB) in combination with IL-2 show an acceptable safety profile. Here, we compared treatment tolerance with and without IL-2. Ninet
Autor:
Kiraz Ceylan, Bjoern N. Lode, Sascha Troschke-Meurer, Holger N. Lode, Luciana J. Jahns, Karoline Ehlert, Nikolai Siebert, Silke Kietz
Publikováno v:
Pediatric Blood & Cancer. 65:e26967
Background The monoclonal anti-GD2 antibody ch14.18/CHO in combination with IL-2 is active and effective in high-risk neuroblastoma (NB) patients. Here, we investigated the inflammatory response and treatment tolerance of long-term infusion (LTI) of